ARCHIVES

Olaparib Study Demonstrates No Changes In Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

Newell, Fredrickson Question Ethics Of Laetrile Trials

July 22, 1977

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

March 23, 1984

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open

March 9, 1979

DeVita To Discuss NCI Plans for CCOPs at ACCC Meetings

January 17, 1986